Angiotensin Receptor-Neprilysin Inhibition for Doxorubicin-Mediated Cardiotoxicity: Time for a Paradigm Shift

Virginia S. Hahn, Kavita Sharma

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)788-790
Number of pages3
JournalJACC: CardioOncology
Issue number5
StatePublished - Dec 2020


  • anthracycline
  • cardio-oncology
  • echocardiography
  • fibrosis
  • heart failure
  • matrix metalloproteinase
  • molecular imaging
  • neprilysin preclinical study
  • treatment

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Oncology

Cite this